Harel Insurance Investments & Financial Services Ltd., a registered investment adviser, initiated a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 44,951,773 shares of the Healthcare company, valued at approximately $1.4B as of the filing date.
Teva Pharmaceutical Industries Limited's stock currently trades at $36.33 with a market capitalization of $34.6B.